Batavia Biosciences is a service company dedicated to add value to customers by providing high quality biopharmaceuticals for proof-of-concept studies & clinical studies, as well as aid product development for all major classes of biopharmaceuticals. The company focuses on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development (mammalian, microbial & insect cell platforms), purification development, product characterization, and clinical manufacturing.
Batavia Biosciences aims to significantly contribute to ease human suffering from disease by improving the success rate in the translation of candidate medicines from discovery to the clinic. In the rapidly growing market of biopharmaceuticals we offer our novel technologies and know how in order to help our customers to complete their preclinical phases in product development at higher speed, reduced cost, and with higher success rate.